• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

依从性良好人群中的苯妥英清除率:描述与应用

Phenytoin clearances in a compliant population: description and application.

作者信息

Graves N M, Leppik I E, Termond E, Taylor J W

出版信息

Ther Drug Monit. 1986;8(4):427-33. doi: 10.1097/00007691-198612000-00009.

DOI:10.1097/00007691-198612000-00009
PMID:3824428
Abstract

The saturable elimination kinetics of phenytoin (PHT) makes accurate dosing difficult. A simple equation has been derived to predict dosing requirements if one dose--steady-state serum concentration pair is known [new dose = first dose X Cpss (desired)0.2 X Cpss (achieved)-0.2]. This equation is based on an exponential relation between 177 pairs of PHT clearance and steady-state serum concentrations from 59 compliant patients. To evaluate this population clearance method (PCM), patients were drawn from two independent populations (Minnesota and Iowa, U.S.A.). Predicted doses obtained from PCM were compared with predictions from Bayesian, average Vmax, and average Km methods. The Bayesian method was the most precise and least biased of all methods, under- and overpredicting doses in equal frequency. PCM was biased to produce underpredictions. However, clinically achievable doses can be obtained by consistently rounding the calculated dose upward. The mean underprediction for the Bayesian method was 6 mg, for PCM 46 mg, for average Vmax 21 mg, and for average Km 11 mg. PCM is relatively precise, somewhat biased, and very easy to use.

摘要

苯妥英(PHT)的饱和消除动力学使得准确给药变得困难。如果已知一个剂量-稳态血清浓度对,则已推导了一个简单方程来预测给药需求[新剂量 = 首次剂量×Cpss(期望)^0.2×Cpss(实际达到)^ -0.2]。该方程基于来自59例依从性良好患者的177对PHT清除率与稳态血清浓度之间的指数关系。为评估这种群体清除率方法(PCM),从两个独立群体(美国明尼苏达州和爱荷华州)选取患者。将PCM得到的预测剂量与贝叶斯方法、平均Vmax和平均Km方法的预测结果进行比较。贝叶斯方法在所有方法中最为精确且偏差最小,预测剂量过低和过高的频率相同。PCM存在偏差,倾向于产生过低预测。然而,通过始终将计算出的剂量向上取整可获得临床上可达到的剂量。贝叶斯方法的平均过低预测为6 mg,PCM为46 mg,平均Vmax为21 mg,平均Km为11 mg。PCM相对精确,有一定偏差,且非常易于使用。

相似文献

1
Phenytoin clearances in a compliant population: description and application.依从性良好人群中的苯妥英清除率:描述与应用
Ther Drug Monit. 1986;8(4):427-33. doi: 10.1097/00007691-198612000-00009.
2
A new approach to establishing individualized maintenance doses of phenytoin.
Ther Drug Monit. 1985;7(4):391-400. doi: 10.1097/00007691-198512000-00005.
3
Bayesian regression analysis of non-steady-state phenytoin concentrations: evaluation of predictive performance.非稳态苯妥英浓度的贝叶斯回归分析:预测性能评估
Ther Drug Monit. 1989;11(4):455-62.
4
A method for prediction of phenytoin levels in the acute clinical setting.一种在急性临床环境中预测苯妥英水平的方法。
Comput Biomed Res. 1991 Dec;24(6):564-75. doi: 10.1016/0010-4809(91)90040-4.
5
Comparison of methods for the prediction of phenytoin concentrations.
J Clin Pharm Ther. 1991 Feb;16(1):55-62. doi: 10.1111/j.1365-2710.1991.tb00284.x.
6
Systematic approach to a dosage regimen for phenytoin based on one-point, steady-state plasma concentration.
Ther Drug Monit. 1995 Feb;17(1):12-8. doi: 10.1097/00007691-199502000-00003.
7
Clinical utility of a Bayesian dosing program for phenytoin.苯妥英钠贝叶斯给药程序的临床效用。
Ther Drug Monit. 1989;11(3):285-94. doi: 10.1097/00007691-198905000-00011.
8
Clinical utility of a new and simple technique for individualizing phenytoin dosage.一种用于个体化苯妥英钠剂量的新型简易技术的临床效用。
J Pharmacobiodyn. 1989 Apr;12(4):187-92. doi: 10.1248/bpb1978.12.187.
9
Phenytoin dosage adjustment method using population clearance.
Chem Pharm Bull (Tokyo). 1990 Feb;38(2):510-2. doi: 10.1248/cpb.38.510.
10
Michaelis-Menten kinetics and the steady-state serum phenytoin/hydroxyphenytoin ratio.
Ther Drug Monit. 1985;7(4):405-10. doi: 10.1097/00007691-198512000-00007.

引用本文的文献

1
Factors in Variability of Serial Gabapentin Concentrations in Elderly Patients with Epilepsy.老年癫痫患者中加巴喷丁浓度的变化的影响因素。
Pharmacotherapy. 2017 Oct;37(10):1197-1203. doi: 10.1002/phar.2012. Epub 2017 Sep 19.
2
Evaluation of a bayesian pharmacokinetic program for phenytoin concentration predictions in outpatient population.
Eur J Drug Metab Pharmacokinet. 1998 Apr-Jun;23(2):295-300. doi: 10.1007/BF03189354.
3
Optimisation of antiepileptic drug therapy. The importance of serum drug concentration monitoring.抗癫痫药物治疗的优化。血清药物浓度监测的重要性。
Clin Pharmacokinet. 1996 Aug;31(2):120-30. doi: 10.2165/00003088-199631020-00004.
4
Therapeutic drug monitoring of phenytoin. Rationale and current status.苯妥英钠的治疗药物监测。基本原理与现状。
Clin Pharmacokinet. 1990 Nov;19(5):341-58. doi: 10.2165/00003088-199019050-00001.
5
An updated comparison of drug dosing methods. Part I: Phenytoin.
Clin Pharmacokinet. 1991 Mar;20(3):209-17. doi: 10.2165/00003088-199120030-00003.
6
Bayesian parameter estimation and population pharmacokinetics.
Clin Pharmacokinet. 1992 Jun;22(6):447-67. doi: 10.2165/00003088-199222060-00004.
7
Pharmacokinetic optimisation of anticonvulsant therapy.抗惊厥治疗的药代动力学优化
Clin Pharmacokinet. 1992 Sep;23(3):216-30. doi: 10.2165/00003088-199223030-00004.